These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7419962)

  • 1. Effect of complement on collagen-induced platelet aggregation.
    Tiffany ML; Penner JA
    J Lab Clin Med; 1980 Nov; 96(5):796-802. PubMed ID: 7419962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules.
    Suba EA; Csako G
    J Immunol; 1976 Jul; 117(1):304-9. PubMed ID: 1084367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human blood platelets possess specific binding sites for C1q.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1987 Mar; 138(5):1537-41. PubMed ID: 3492557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG.
    Wautier JL; Souchon H; Solal LC; Peltier AP; Caen JP
    Immunology; 1976 Oct; 31(4):595-9. PubMed ID: 185144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of C1 subcomponents in platelet aggregation induced by aggregated IgG].
    Wautier JL; Souchon H; Peltier AP; Caen JP
    Ann Immunol (Paris); 1977; 128(1-2):81-2. PubMed ID: 848910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A physiologic regulator of collagen-induced platelet aggregation: inhibition by Clq.
    Csákó G; Suba EA
    Thromb Haemost; 1981 Apr; 45(2):110-5. PubMed ID: 7256694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free platelet count and size distribution during C1q inhibition of collagen-induced platelet aggregation.
    Csako G; Suba EA
    Thromb Haemost; 1987 Aug; 58(2):682-5. PubMed ID: 3499680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
    Doekes G; van Es LA; Daha MR
    J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the C4-binding site on C1s with monoclonal antibodies. Evidence for a C4/C4b-binding site on the gamma-domain.
    Matsumoto M; Nagaki K; Kitamura H; Kuramitsu S; Nagasawa S; Seya T
    J Immunol; 1989 Apr; 142(8):2743-50. PubMed ID: 2522968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First component of complement and thrombosis.
    Wautier JL; Ollier-Hartmann MP; Kadeva H; Cohen F; Hartmann L; Caen JP
    Thromb Haemost; 1981 Jun; 45(3):247-51. PubMed ID: 7281103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1q binding and C1 activation by various isolated cellular membranes.
    Storrs SB; Kolb WP; Olson MS
    J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel 33-kDa C1q-binding site on human blood platelets.
    Peerschke EI; Reid KB; Ghebrehiwet B
    J Immunol; 1994 Jun; 152(12):5896-901. PubMed ID: 8207215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of the prime subsites of the C1s protease of the classical complement pathway for recognition of substrates.
    O'Brien G; Quinsey NS; Whisstock JC; Pike RN
    Biochemistry; 2003 Dec; 42(50):14939-45. PubMed ID: 14674770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the early components of the classical complement pathway under physiologic conditions.
    Ziccardi RJ
    J Immunol; 1981 May; 126(5):1769-73. PubMed ID: 7217665
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
    Gyongyossy-Issa MI; McLeod E; Devine DV
    J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarities and dissimilarities between the binding ability of C1q and collagen.
    Csákó G; Suba EA; Herp A
    Clin Exp Immunol; 1981 Apr; 44(1):181-90. PubMed ID: 7261474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
    Jiang H; Burdick D; Glabe CG; Cotman CW; Tenner AJ
    J Immunol; 1994 May; 152(10):5050-9. PubMed ID: 8176223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.